Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 4
2016 3
2019 1
2020 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials.
Lang AE, Rodriguez RL, Boyd JT, Chouinard S, Zadikoff C, Espay AJ, Slevin JT, Fernandez HH, Lew MF, Stein DA, Odin P, Fung VS, Klostermann F, Fasano A, Draganov PV, Schmulewitz N, Robieson WZ, Eaton S, Chatamra K, Benesh JA, Dubow J. Lang AE, et al. Among authors: benesh ja. Mov Disord. 2016 Apr;31(4):538-46. doi: 10.1002/mds.26485. Epub 2015 Dec 23. Mov Disord. 2016. PMID: 26695437 Free PMC article.
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.
Fernandez HH, Standaert DG, Hauser RA, Lang AE, Fung VS, Klostermann F, Lew MF, Odin P, Steiger M, Yakupov EZ, Chouinard S, Suchowersky O, Dubow J, Hall CM, Chatamra K, Robieson WZ, Benesh JA, Espay AJ. Fernandez HH, et al. Among authors: benesh ja. Mov Disord. 2015 Apr;30(4):500-9. doi: 10.1002/mds.26123. Epub 2014 Dec 24. Mov Disord. 2015. PMID: 25545465 Free PMC article. Clinical Trial.
A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies.
Boyd JT, Zadikoff C, Benesh JA, Zamudio J, Robieson WZ, Kukreja P, Yokoyama M, Siddiqui MS. Boyd JT, et al. Among authors: benesh ja. Clin Park Relat Disord. 2019 Dec 11;2:25-34. doi: 10.1016/j.prdoa.2019.12.001. eCollection 2020. Clin Park Relat Disord. 2019. PMID: 34316616 Free PMC article.